Tanvex BioPharma, Inc. (6541.TW) - Stock Prices, Stock Peers & Analysis

Home
6541.TW

Company Name	Tanvex BioPharma, Inc.
Symbol	6541.TW
Currency	TWD
Price	62.3
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	10,221,623,300
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	35.05 - 80
Industry	Biotechnology
Sector	Healthcare
CEO	Dr. Yun Yen F.A.C.P., FACP, M.D., Ph.D.
Website	https://www.tanvex.com

An error occurred while fetching data.

About Tanvex BioPharma, Inc.

Tanvex BioPharma, Inc., a biopharmaceutical company, engages in the research, development, manufacture, and sale of biosimilar in Taiwan and the United States. The company focuses on delivering biosimilars which target neutropenia, breast cancer, metastatic colorectal cancer, and psoriasis. Its products pipeline includes TX01 and TX-05 which have completed Phase III